Chinese ministry, WHO warn of antibiotic overuse

April 7, 2011 By GILLIAN WONG , Associated Press

(AP) -- Drug-resistant forms of diseases such as tuberculosis are on the rise in China because of the overuse of antibiotics and urgent action is needed to reverse the problem, the Health Ministry and the World Health Organization warned Thursday.

Vice Health Minister Ma Xiaowei said at a ceremony to mark World Health Day that he hoped hospitals would push for antibiotics to be used in "scientific and rational" ways.

About 6.8 percent of tuberculosis cases in China are multiple-drug resistant, far higher than the 2 percent rate in most developed countries, said Dr. Michael O'Leary, the WHO's representative in China.

Antibiotics can spur infection-causing bacteria to become drug-resistant if they are overused. Drug-resistant tuberculosis can also arise when people take substandard medicines, a common problem in China. It takes longer to treat than regular TB and requires more expensive drugs, which also cause bad side effects such as .

"Infections caused by resistant often fail to respond to conventional treatment, resulting in prolonged illness and greater risk of death," O'Leary said.

He said that action was needed now because new drugs cannot be developed fast enough to replace the drugs that have lost their effectiveness.

A WHO statement said about 440,000 new cases of multidrug-resistant tuberculosis emerge around the world each year, causing at least 150,000 deaths.

The overuse of antibiotics is very common in China, often because it is a way for hospitals to boost revenue.

Antibiotics are also misused in the food industry, showing up in diverse parts of the from farmed fish to honey.

Dr. Fabio Scano, a WHO medical officer with the TB program in China, said 50 percent of antibiotics used globally are misused on animals in food production. Scano said there's evidence that "the more antibiotics are used, the higher is the in humans."

Explore further: Uncovering new treatments for drug-resistant tuberculosis

shares

Related Stories

Uncovering new treatments for drug-resistant tuberculosis

June 17, 2016
For most Australians tuberculosis is a disease of yesteryear, but leading immunologists from UTS and India's Jawaharlal Nehru University (JNU) are partnering to combat what they call a future health crisis.

Global rise of multidrug resistant tuberculosis threatens to derail decades of progress

March 23, 2017
New antibiotics are becoming available for the first time but without accurate diagnostics, clear treatment guidelines, and improved control efforts, their effectiveness could be rapidly lost

Growing presence of drug-resistant tuberculosis fuels need for faster development of new combination therapies

June 6, 2012
Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with ...

No consensus on how the microbiome affects tuberculosis, review finds

September 7, 2016
Inconsistencies across studies and sampling errors remain major barriers to understanding how the lung microbiome changes with tuberculosis, according to a review published Wednesday in Clinical Microbiology Reviews.

China faces 'serious' epidemic of drug-resistant TB (Update)

June 6, 2012
China faces a "serious epidemic" of drug-resistant tuberculosis according to the first-ever nationwide estimate of the size of the problem there, said a US-published study on Wednesday.

New research points to elderly as growing contributor to tuberculosis in China

April 21, 2015
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.